logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Primaquine Diphosphate CAS 63-45-6

Primaquine Diphosphate CAS 63-45-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 63-45-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
63-45-6
Appearance::
Orange Powder
Molecular Formula::
C15H27N3O9P2
Molecular Weight::
455.33700
EINECS NO::
200-560-8
MDL NO::
MFCD00013166
CAS NO::
63-45-6
Appearance::
Orange Powder
Molecular Formula::
C15H27N3O9P2
Molecular Weight::
455.33700
EINECS NO::
200-560-8
MDL NO::
MFCD00013166
Primaquine Diphosphate CAS 63-45-6

Product Description:

Product Name: Primaquine diphosphate CAS NO: 63-45-6

 

 

Synonyms:

4-N-(6-metho-xyquinolin-8-yl)pentane-1,4-diamine,phosphoric acid;

8-(4-amino-1-methylbutylamino)-6-metho-xyquinoline diphosphate salt;

4-pentanediamine, n(sup 4)-(6-metho-xy-8-quinolinyl)- phosphate;

 

 

Chemical & Physical Properties:

Appearance: Orange powder

Assay :≥99.00%

Boiling Point: 451.1℃ at 760 mmHg

Melting Point: 199-205℃

Flash Point: 226.6℃

Water Solubility: Moderately soluble

Stability: Stable. Incompatible with strong oxidizing agents.

Storage Condition: Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

 

 

Safety Information:

RTECS: VA9660000

Hazard Class: 6.1(b)

Safety Statement: S45

HS Code: 2933499090

WGK Germany: 3

Packing Group: III

RIDADR: UN 2811

Risk Statement: R25

Hazard Code: T

 

 

Primaquine diphosphate is an established antimalarial drug used in the treatment of persistent liver forms of P. vivax or P. ovale infection for its ability to kill late-stage gametocytes and hypnozoites. In historical terms, this aminoquinoline was the stimulus for the discovery of glucose-6-phosphate (G6P) dehydrogenase deficiency as it induced hemolytic anemia in patients lacking the G6P-metabolizing enzyme.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.